Paladin Advisory Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-924
Closed -$86.1K 316
2022
Q4
$86.1K Sell
924
-170
-16% -$16.4K 0.07% 129
2022
Q3
$104K Hold
1,094
0.09% 121
2022
Q2
$101K Buy
+1,094
New +$107K 0.09% 125
2022
Q1
Sell
-1,094
Closed -$112K 327
2021
Q4
$112K Buy
+1,094
New +$101K 0.09% 129

Other funds holding CVS

Paladin Advisory Group's CVS Position: Q1 2025 in Review

Paladin Advisory Group sold out of CVS Health (CVS) in Q1 2025, closing a stake of 574 shares — an estimated $25.8K sold.

Paladin Advisory Group first reported a position in CVS in Q1 2022 and held it in 9 quarters. The position peaked at $110K in Q1 2022. 1,756 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Paladin Advisory Group reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Paladin Advisory Group sold 574 CVS Health shares in Q1 2025, an estimated $25.8K.
  • Paladin Advisory Group first reported a position in CVS Health in Q1 2022 and held it in 9 quarters.
  • Paladin Advisory Group's CVS Health position peaked at $110K in Q1 2022.
  • 1,756 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Paladin Advisory Group's 13F filing for Q1 2025, filed 15 Apr 2025.